Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma

NCT01887340 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

271

Enrollment

OTHER

Sponsor class

Conditions

Seminoma

Interventions

DRUG: Carboplatin
DRUG: Etoposide
DRUG: Cisplatin

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris